{{Rsnum
|rsid=3093105
|Gene=CYP4F2
|Chromosome=19
|position=15897578
|Orientation=plus
|ReferenceAllele=T
|MissenseAllele=G
|GMAF=0.1566
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=CYP4F2
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 0.0 | 0.0 | 0.0
| HCB | 0.0 | 16.7 | 83.3
| JPT | 0.0 | 6.8 | 93.2
| YRI | 0.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 16.7 | 83.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19097922
|Title=A haplotype of the CYP4F2 gene associated with myocardial infarction in Japanese men.
}}

{{PMID Auto
|PMID=18235092
|Title=Association of a functional cytochrome P450 4F2 haplotype with urinary 20-HETE and hypertension.
|OA=1
}}

{{PMID Auto
|PMID=18250228
|Title=CYP4F2 genetic variant alters required warfarin dose.
|OA=1
}}

{{PMID Auto
|PMID=18787519
|Title=A haplotype of the CYP4F2 gene is associated with cerebral infarction in Japanese men.
}}

{{PMID Auto
|PMID=18971550
|Title=Haplotype-based case-control study of the human CYP4F2 gene and essential hypertension in Japanese subjects.
}}

{{PMID Auto
|PMID=19957603
|Title=[Association on the haplotypes of CYP4F2 gene and myocardial infarction].
}}

{{GET Evidence
|gene=CYP4F2
|aa_change=Trp12Gly
|aa_change_short=W12G
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs3093105
|overall_frequency_n=2053
|overall_frequency_d=10742
|overall_frequency=0.191119
|n_genomes=21
|n_genomes_annotated=0
|n_haplomes=24
|n_articles=0
|n_articles_annotated=0
|pph2_score=0.001
|nblosum100=7
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}